PRODUCT INFORMATION
Home / Our Products
WARNINGS
When using Rapanofal® injection, patients should be continuously monitored and facilities for the maintenance of a patent airway, artificial ventilation, and oxygen supplementation must be immediately available. The clinical use of propofol without available supplemental oxygen and artificial ventilation has not been adequately evaluated and is not recommended.
| NDC NUMBER |
| 86064-001-20 |
| STRENGTH |
| 10mg/mL |
| VIAL SIZE |
| 20mL |
| CONTAINER TYPE |
| VIALS |
| PACK |
| 5 VIALS |
PRODUCT INFORMATION
| Case Quantity: | 18 Packs |
| Package Insert: | Rapanofal® (propofol injectable emulsion) Anesthetic Injection |
| Safety Data Sheet (SDS): | Download PDF |
| Storage: | Store between 4 – 25°C (40-77°F). Do not freeze. Shake well before use. Discard opened vial with care. Within 6 hours after opening, any withdrawn unused product should be discarded safely |
Rapanofal® is the only FDA-approved propofol anesthetic injection formulated specifically for use in both dogs and cats. Rapanofal® allows veterinarians to provide safe and effective anesthesia for a wide range of procedures.
Induce anesthesia within 30-60 seconds and witness swift recovery in both dogs (5-7 minutes) and cats (varies based on pre-anesthetics and maintenance doses).
Suitable for induction and maintenance of anesthesia, as well as standalone anesthesia for short procedures.
Rapanofal® is a go-to choice for veterinary professionals seeking a versatile anesthetic solution. With FDA approval for both dogs and cats, it streamlines the anesthesia process, providing a single, reliable option for a range of veterinary procedures.
With its proven safety profile and efficacy, Rapanofal offers peace of mind to veterinarians and pet owners alike during anesthesia procedures.
Refer to the package insert for more information, or if you have additional questions, check out our FAQ page or contact us directly at 844.243.4968
©Copyright 2024. All Rights Reserved.